DUBLIN--(BUSINESS WIRE)--The "Medical Feed Additives Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.
The global medical feed additives market was valued at about $13.01 billion in 2018 and is expected to grow to $16.3 billion at a CAGR of 5.8% through 2022.
The medical feed additives market consists of sales of medical feed additives and related services in order to prepare complete food for animals. Medical feed additives help improve the nutritional content and quality of feed, results in better productivity, and prevents animals from diseases. Medical feed additives industry includes companies that produce animal feed additives such as vitamins and probiotic, preservatives, antioxidants, digestibility enhancers, gut flora stabilizers and others.
The medical feed additives market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for Medical Feed Additives and is expected to continue to be the largest market during the forecast period.
Increase in prevalence of diseases among animals is driving the growth of the medicated feed additives market. According to the estimates from report by Defra, 2017, the prevalence rate of bovine tuberculosis (TB) in cattle increased in England from 5.7% in 2016 to 6% in 2017. Bovine tuberculosis is a chronic disease which usually affects animals such as cattle, but it can affect all mammals causing illness, coughing and eventual death.
Also, in June 2017, the rate of new herd incidents per 100 herd years at risk stood at 10.7, compared with 10.1 in June 2016, indicating the level of risk of cattle. A new herd incident is a case of bovine TB that occurs as a result of a herd or individual animal test performed in an officially TB-free (OTF) herd during the study period. Moreover, according to the reports in The Pan African Medical Journal, 2018, Nigeria revealed the prevalence of bovine tuberculosis up to 15.1%. The additives help prevent animals from diseases alongside increasing the nutrition level of the feed thereby increasing demand for feed additives.
The overuse and inappropriate use of antibiotics in medical feed additives impacts the health of individuals consuming the animal meat or other related products. Moreover, the health of the animal consuming the feed may also be adversely affected by the antibiotics added to the feed as the excess additive reduces the natural immunity of the animal and increases susceptibility of the livestock to infections.
For instance, in 2016, the Chinese Ministry of Agriculture banned the use of the antibiotic Colistin as a feed additive for animals when the UK-China antimicrobial research found that Colistin, a drug used to treat pneumonia and malaria in humans, when consumed by humans through animal meat makes the drug less effective to treat pneumonia and malaria in humans. The ban resulted in the withdrawal of more than 8,000 tons of Colistin as a growth promoter from the Chinese medicated feed additive market sector and directing all the manufacturers to update the feed formulation. The negative effects of additives on human health will restrain the growth of the market.
Companies in the medical feed additives market are introducing new feed medicated additives formed as a result of combination of two or more medicated feed additives. More than 70% of manufacturers are now using more than one feed additive in animal feed to increase the efficiency of the product. For instance, in 2018, Zoetis, a global health company got the approval for its Cyden and Lincomix combination feed additive from the FDA (Food and Drug Administration) and is proposed to be used as medicated feed additive for poultry. Also, in 2015, FDA approved combination of Zoetis' feed additives ACTOGAIN 45 (ractopamine hydrochloride) and ENGAIN (ractopamine hydrochloride) that makes more lean muscle and less fat while optimizing feed efficiency.
The medical feed additives market is regulated by government agencies which lay down regulations to be followed by all the manufacturers of veterinary medicines.
For instance, the Veterinary Medicines Regulations (VMR) 2013 makes provision for the authorization, manufacturing and classification of veterinary products including medicated feed additives. The Schedule 5 under EU guidelines covers medicated feeding stuffs and specified feed additives which specifies guidance to both manufactures and suppliers of veterinary medicines for incorporating it into animal feed as well as to veterinary surgeons, animal keepers and other members involved in the use of veterinary medicines and SFAs(Specified Feed Additives)in animal feeding stuffs.
In February 2019, Archer Daniels Midland Company (ADM), an American global food processing and commodities trading company acquired Neovia for $1.74 billion (1.544 billion). This acquisition helps ADM to become a global leader in animal nutrition products and services with Neovia adding a wide range of products to the former company's portfolio including pet care, additives, aquaculture, and livestock feed which would in turn boost the growth of the company. Neovia is headquartered in France was established in 1954 and manufactures and distributes various biologically degradable disinfectants along with feed additives for plants and animals.
Major players in the market are Zoetis Inc., Cargill,, CHS Inc., Purina Animal Nutrition (Land O' Lakes) and Archer Daniels Midland Company.
For more information about this report visit https://www.researchandmarkets.com/r/gc1vt9